PKC-δ signalling pathway is involved in H9c2 cells differentiation

Differentiation

Volumn 80, Issue 4-5, 2010, Pages 204-212

  Giacomo, Viviana di ^a,b   Rapino, Monica ^c   Sancilio, Silvia ^a   Patruno, Antonia ^a   Zara, Susi ^a,b   Di Pietro, Roberta ^a   Cataldi, Amelia ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b Facolta di Farmacia   (Italy)

^c Istituto di Genetica Molecolare Del CNR   (Italy)

Author keywords

Differentiation; H9c2; NOS; PKC

Indexed keywords

CYCLIN A; LIPOCORTIN 5; MYOGENIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN BAX; PROTEIN KINASE C DELTA; REACTIVE OXYGEN METABOLITE; ROTTLERIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRAIN; CELL STRAIN H9C2; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE ACTIVATION; GENE SILENCING; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; MYOBLASTS; NITRIC OXIDE; PROTEIN KINASE C-DELTA; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

RATTUS;

EID: 78049284254     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2010.06.002     Document Type: Article

References (49)

1. Baba T.T., Nemoto T.K., Miyazaki T., Oida S. Simvastatin suppresses the differentiation of C2C12 myoblast cells via a Rac pathway. J. Muscle Res. Cell Motil. 2008, 29:127-134.
2. Barnett M.E., Madgwick D.K., Takemoto D.J. Protein Kinase C as a stress sensor. Cell Signall. 2007, 19:1820-1829.
3. Barreiro Arcos M.L., Gorelik G., Klecha A., Genaro A.M., Cremaschi G.A. Thyroid hormones increase inducible nitric oxide synthase gene expression downstream from PKC-zeta in murine tumor T lymphocytes. Am. J. Physiol. Cell Physiol. 2006, 291:C327-C336.
4. Beckman K.B., Ames B.N. The free radical theory of aging. Physiol. Rev. 1998, 78:547-581.
5. Bedada F.B., Braun T. Partial induction of the myogenic program in noncommitted adult stem cells. Cells Tissues Organs 2008, 188:189-201.
6. Brune B., Lapetina E.G. Protein thiol modification of glyceraldehyde-3-phosphate dehydrogenase as a target for nitric oxide signalling. Gen. Eng. 1995, 17:149-164.
7. Brunner F., Andrew P., Wölkart G., Zechner R., Mayer B. Myocardial contractile function and heart rate in mice with myocyte-specific over-expression of endothelial nitric oxide synthase. Circulation 2001, 104:3097-3102.
8. Buggish M., Ateghang B., Ruhe C., Strobel C., Lange S., Wartenberg M., Sauer H. Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase. J. Cell Sci. 2007, 120:885-894.
9. Chun Y.K., Kim J., Kwon S., Choi S.H., Hong F., Moon K, Kim JM, Choi SL, Kim BS, Ha J, Kim SS. Phosphatidylinositol 3-kinase stimulates muscle differentiation by activating p38 mitogen-activated Protein Kinase. Biochem. Biophys. Res. Commun. 2000, 276:502-507.
10. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 2001, 282:1075-1079.
11. Czifra G., Tóth I.B., Marincsák R., Juhász I., Kovács I., Acs P., Kovács L., Blumberg P.M., Bíró T. Insulin-like growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells and in C2C12 myoblasts. A central role of Protein Kinase C delta. Cell Signal. 2006, 18:1461-1472.
12. Di Pietro R., Mariggiò M.A., Guarnieri S., Sancilio S., Giardinelli A., Di Silvestre S., Consoli A., Zauli G., Pandolfi A. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC). J. Cell Biochem. 2006, 291:C327-C336.
13. Fernando P., Kelly J.F., Balazsi K., Slack R.S., Megeney L.A. Caspase-3 activity is required for skeletal muscle differentiation. PNAS 2002, 99:11025-11030.
14. Gopalakrishna R., Jaken S. Protein Kinase C signalling and oxidative stress. Free Rad. Biol. Med. 2000, 28:1349-1361.
15. Gould C.M., Newton A.C. The life and death of Protein Kinase C. Curr. Drug Targ. 2008, 9:614-625.
16. Gow A.J., Buerk D.G., Ischiropoulos H. A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J. Biol. Chem. 1997, 272:2841-2845.
17. Gow A.J., Luchsinger B.P., Pawloski J.P., Singel D.J., Stamler J.S. The oxy-hemoglobin reaction of nitric oxide. Proc. Natl. Acad. Sci. USA 1999, 96:9027-9032.
18. Gow A.J., Ischiropoulos H. Nitric oxide chemistry and cellular signalling. J. Cell Physiol. 2001, 18:277-282.
19. Grzelkowska-Kowalczyk K., Wieteska-Skrzeczyńska W. Treatment with TNF-alpha and IFN-gamma alters the activation of SER/THR Protein Kinases and the metabolic response to IGF-I in mouse c2c12 myogenic cells. Cell Mol. Biol. Lett. 2009, 15:13-31.
20. Gschwendt M., Muller H.J., Kielbasse K., Zang R., Kittstein W., Rincke G., Marks F. Rottlerin, a novel Protein Kinase inhibitor. Biochem. Biophys. Res. Commun. 1994, 199:93-98.
21. Hong F., Lee J., Song J.W., Lee S.J., Ahn H., Cho J.J., Ha J., Kim S.S. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporine A-induced cytotoxicity. FASEB J. 2002, 16:1633-1635.
22. Hunter A.L., Zhang J., Chen S.C., Si X., Wong B., Ekhterae D., Luo H., Granville D.J. Apoptosis repressor with caspase recruitment domain (ARC) inhibits myogenic differentiation. FEBS Lett. 2007, 581:879-884.
23. Kageyama K., Ihara Y., Goto S., Urata Y., Toda G., Yano K., Kondo T. Overexpression of calreticulin modulates Protein Kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J. Biol. Chem. 2002, 277:19255-19264.
24. Kaliman P., Canicio J., Testar X., Palacín M., Zorzano A. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J. Biol. Chem. 1999, 274:17437-17444.
25. Karimi G., Fatehi Z., Gholamnejad Z. The role of nitric oxide and Protein Kinase C in lipopolysaccharide-mediated vascular hyporeactivity. J. Pharm. Pharmaceut. Sci. 2006, 9:119-123.
26. Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 1997, 272:31138-31148.
27. Kimes B.W., Brandt B.L. Properties of a clonal muscle cell line from rat heart. Exp. Cell. Res 1976, 98:367-381.
28. Kook S.H., Lee H.J., Chung W.T., Hwang I.H., Lee S.A., Kim B.S., Lee J.C. Cyclic mechanical stretch stimulates the proliferation of C2C12 myoblasts and inhibits their differentiation via prolonged activation of p38 MAPK. Mol. Cells 2008, 25:479-486.
29. Liu Z., Jiang Y., Hao H., Kalpna G., Xu J., Chu L., McFalls E., Zweier J., Verfaillie C., Bache R.J. Endothelial nitric oxide synthase is dynamically expressed during bone marrow stem cells differentiation into endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1760-H1765.
30. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852.
31. Pagano M., Naviglio S., Spina A., Chiosi E., Castoria G., Romano M., Sorrentino A., Illiano F., Illiano G. Differentiation of H9c2 cardiomyoblasts: the role of adenylate cyclase system. J. Cell Physiol. 2004, 198:408-416.
32. 2. Mol. Cell. Biol. 2004, 24:4384-4394.
33. Piao Y.J., Seo Y.H., Hong F., Kim J.H., Kim Y.J., Kang M.H., Kim B.S., Jo S.A., Jo I., Jue D.M., Kang I., Ha J., Kim S.S. Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway. Free Rad. Biol. Med 2005, 38:989-1001.
34. Ramazzotti G., Faenza I., Gaboardi G.C., Piazzi M., Bavelloni A., Fiume R., Manzoli L., Martelli A.M., Cocco L. Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. Cell Signal. 2008, 20:2013-2021.
35. Ramzy D., Rao V., Tumiati L.C., Xu N., Sheshgiri R., Miriuka S., Delgado D.H., Ross H.J. Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation 2006, 114:1319-1326.
36. Rashid G., Bernheim J., Green J., Benchetrit S. Parathyroid hormone stimulates the endothelial nitric oxide synthase through Protein Kinase A and C pathways. Nephrol. Dial. Transplant. 2007, 22:2831-2837.
37. Sabourin L.A., Rudnicki M.A. The molecular regulation of myogenesis. Clin. Genet. 2000, 57:16-25.
38. Sedoris K.C., Ovechkin A.V., Gozal E., Roberts A.M. Differential effects of nitric oxide synthesis on pulmonary vascular function during lung ischemia-reperfusion injury. Arch. Physiol. Biochem 2009, 115:34-46.
39. Shaul P.W. Regulation of endothelial nitric oxide synthase: location, location, location. Annu. Rev. Physiol. 2002, 64:749-774.
40. Slezak J., Buchwalow I.B., Schulze W., Karczewski P., Wallukat G., Samoilova V.E., Krause E.G., Neumann J., Haller H. Cellular control of nitric oxide synthase expression and activity in rat cardiomyocytes. Antioxid. Redox Signal. 2004, 6:345-352.
41. Soltoff S.P. Rottlerin: an inappropriate and ineffective inhibitor of PKC-δ. Trends Pharmacol Sci. 2007, 9:453-458.
42. Stamler J.S., Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 2001, 81:209-237.
43. Steinberg S.F. Structural basis of Protein Kinase C isoform function. Physiol. Rev. 2008, 88:1341-1378.
44. Suziki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Rad. Biol. Med. 1997, 22:269-285.
45. Suzuki N., Urano J., Tamanoi F. Farnesyltransferase inhibitors induce cytochrome c release and caspase-3 activation preferentially in transformed cells. Proc. Natl. Acad. Sci. USA 1998, 95:15356-15361.
46. Tsakiridis T., Tsiani E., Lekas P., Bergman A., Cherepanov V., Whiteside C., Downey G.P. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells. Biochem. Biophys. Res. Commun. 2001, 288:205-211.
47. Yoshizumi M., Lee W.S., Hsieh C.M., Tsai J.C., Li J., Perrella M., Patterson C., Endege W.O., Schlegel R., Lee M.E. Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle. J. Clin. Invest. 1995, 95:2275-2280.
48. Zhang Z., Leonard S.S., Huang C., Vallyathan V., Castranova V., Shi X. Role of reactive oxygen species and MAPKS in vanadate-induced G(2)/M phase arrest. Free Rad. Biol. Med. 2003, 34:1333-1342.
49. Zhao X., Li X., Trusa S., Olson S.C. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells. Regul. Pept 2005, 132:113-122.